Invajo - Events tool


25th MARCH 2021
A virtual event broadcast from a studio in Stockholm
13.00 – 17.00 CET

Welcome and introduction
Eva Tiensuu Janson, Uppsala University, Uppsala, Sweden
Judith Miedema, Ipsen Nordic-Baltic

Tumor Growth Rate – a new way to predict therapy response and outcome
Angela Lamarca, Christie NHS Foundation Trust, University of Manchester, United Kingdom

Surgery in GEP NEC, NET G3 and MiNEN
Ulrich Knigge, Rigshospitalet, Copenhagen, Denmark

Treatment of symptoms in SI-NETs, the patients’ perspective
Espen Thiis-Evensen, Rikshospitalet, Oslo, Norway

New plasma Proteins in SI-NETs
Roger Belusa, Ipsen Nordic, Stockholm, Sweden

Real world experience of PRRT in NET – when to adjust the schedule
and when not to treat
Martin Walter, Hôpitaux Universitaires de Genève, Switzerland

Systemic treatment of pheochromocytoma and paraganlioma
Eric Baudin, Institute Gustave Roussy, Villejuif, France

Three Patient cases
– Appendix NET:
Henning Grönbaek, Aarhus University Hospital, Aarhus Denmark
– G2 SI-NET:
Dimitrios Papantoniou, Department of Oncology Ryhov County Hospital,
Jönköping, Sweden
– NET G3:
Halfdan Sørbye, Haukeland University Hospital, Bergen, Norway

Summing up the day & closure of the meeting
Eva Tiensuu Jansson, Uppsala University, Uppsala, Sweden

A detailed agenda will follow closer to the event.

Evolve Meetings is using Invajo´s event tool for managing this event and its attendees. Invajo have no responsibility for the execution of the event. Any questions regarding the event and its content will be answered by Evolve Meetings. For technical questions, please contact Invajo´s support. Your details are handled by Invajo, Evolve Meetings and different subcontractors that are required for the delivery of the products and functions provided by Invajo. By going through with a booking on this event, you also accept Invajos general conditions which are available on